---
created: 2025-04-13
updated: 2025-04-13T10:51
id: zE9@:]aW8<
specialty: neuro
specialty_id: 138
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::13-inhaled-anesthetics
  - source/ak-step1-v11::
  - theme/firstaid::12-neuro-&-special-senses::06-pharm::13-inhaled-anesthetics::malignant-hyperthermia
  - source/ak-step1-v11::
  - source/ome-banner
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::14-neuro::16-inhaled-anesthetics
  - source/ak-step1-v11::
  - theme/pixorize::03-pharm::14-anesthetics::halothane-and-fluranes
  - source/ak-step1-v11::
  - theme/sketchypharm::06-neuro/psych::02-anesthetics-&-analgesics::02-inhaled-anesthetics,-dantrolene
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::neuro::pharmacology"
type: flashcard
---

# Question
What genetic phenomenon is associated with malignant hyperthermia?    **Incomplete penetrance**

---

# Answer
some individuals who have the disease genotype do not display the disease phenotype